Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Terminated(3)
Other(1)

Detailed Status

Terminated2
unknown1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
33.3%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

unknown120%
withdrawn120%
completed120%
terminated240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5